On the other hand, the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway is a critical defense mechanism against oxidative stress, helping to protect cardiac function under pathological conditions, and oxidative stress is the key pathological feature implicated in the development of dyslipidemia-associated cardiovascular complications [116]. Here, NFE2L2 is linked to metabolic syndrome.